Shanghai Acebright Pharmaceuticals Group Co., Ltd. was founded in 1996 and reorganized into a corporate group in 2012. Acebright’s business encompasses active pharmaceutical ingredients (APIs), finished dosage forms, single-ingredient nutritional supplements, and CDMO services, with a focus on anti-infective, anticancer, nutritional, steroid, and small nucleic acid therapies. Leveraging specialized platforms in synthesis, crystallization, microbial fermentation, biotechnology, and formulation technology, Acebright continuously advances the synergy among R&D, production, and supply to provide customers with stable, compliant products and services.
Shanghai Science and Technology Innovation Action Plan,major science and technology project in the field of biomedical and clinical medicine:Research on key technologies for industrialization of antimalarial drug(Artemisinin series products).
Shanghai Science and Technology Innovation Action Plan,industry-university-research and medical cooperation project in the field of biomedicine:The development and clinical research of the first imitation prescription process of Tenofovir Lamivudine and Efavirenz tablets,a new anti-AIDS drug.
Shanghai Science and Technology Innovation Action Plan,international science and technology cooperation project:Introduction of international advanced hot melt extrusion technology and pilot research and development of Azanavir / Ritonavir compound tablets.
Special Fund Project for Industrial Transformation,Upgrading and Development in Shanghai:Introduction of innovative technology of Lamivudine, the first-line drug for AIDS.
Major Scientific And Technological Projects For Major New Drugs Development:Development of urgently needed varieties of anti-AIDS drugs TLE,TLD and EFV.
Major scientific and technological projects for major new drugs development:Clinical trial study of Simmiparib,a first class new drug of Anti-cancer.
National High-tech Research and Development Programs(863 Programs):Molecular improvement and production process optimization and demonstration of Riboflavin bacterial strain.
National Torch Programs:The anti-HIV drug,Ritonavir,industrialization of innovative processes.
National Major Scientific and Technological Achievements Transformation Projects:Research and industrialization of Tenofovir.
Special Projects For The Development Of General Name Chemical Drugs(National Development and Reform Commission):Industrial development of the anti-HIV drug,Lamivudine/Zidovudine/Nevirapine Triple Tablets.
